✦ LIBER ✦

Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma

✍ Scribed by Jason Konner, Rachel N. Grisham, Jae Park, Owen A. O’Connor, Gillian Cropp, Robert Johnson, Alison L. Hannah, Martee L. Hensley, Paul Sabbatini, Svetlana Miranov, Samuel Danishefsky, David Hyman, David R. Spriggs, Jakob Dupont, Carol Aghajanian

Book ID: 118299063
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 270 KB
Volume: 30
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-011-9765-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum to: Phase I clinical, pharmacoki

Erratum to: Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma

✍ Jason Konner, Rachel N. Grisham, Jae Park, Owen A. O’Connor, Gillian Cropp, Robe 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 56 KB

A phase 1 study of KOS-862 (Epothilone D

A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin®) in patients with advanced solid tumors

✍ J. Paul Monk, Miguel Villalona-Calero, Joe Larkin, Greg Otterson, David S. Sprig 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 220 KB

547 KOS-862 (Epothilone D): Phase 1 dose

547 KOS-862 (Epothilone D): Phase 1 dose escalating and pharmacokinetic (PK) study in patients (Pts) with advanced malignancies

✍ D.R. Spriggs; J. Dupont; S. Pezzulli; J. Larkin; G. Cropp; Y. Zhou; M. Sherrill; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 341 KB

Phase I dose escalation study of KOS-158

Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors

✍ Elaine T. Lam; Sanjay Goel; Larry J. Schaaf; Gillian F. Cropp; Alison L. Hannah; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 280 KB

Phase I Dose-Escalation and Pharmacokine

Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors

✍ Demetri, G. D.; Lo Russo, P.; MacPherson, I. R.J.; Wang, D.; Morgan, J. A.; Brun 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 238 KB

Irinotecan in combination with thalidomi

Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation

✍ Giacomo Allegrini; Antonello Di Paolo; Elisa Cerri; Samanta Cupini; Federica Ama 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 249 KB